Legalizing marijuana

Leyton, Marco

doi:10.1503/jpn.160012

Cited by 5 publications

(3 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…f. Cannabis use has other risks also. 1,7 Since legalization has had minimal effects on cannabis use, [8][9][10][11] these outcomes are no more likely to be affected than the primary issues discussed here, traffic fatalities and psychosis. g. Alcohol prohibition in the early 20th century decreased consumption in some quarters 12 but ultimately was rejected for converging social, political and economic reasons.…”

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

Cannabis legalization: Did we make a mistake? Update 2019

Leyton

2019

jpn

Self Cite

View full text Add to dashboard Cite

Section: Resultsmentioning

confidence: 99%

“…In the fall of 2015, I wrote a JPN editorial endorsing the proposed Canadian legalization of cannabis for nonmedical purposes. 1 This brief comment elicited one of the largest responses of my career. Strong opinions were expressed, with roughly half agreeing, the other half not.…”

mentioning

confidence: 99%

Cannabis legalization: Did we make a mistake? Update 2019

Leyton

2019

jpn

Self Cite

View full text Add to dashboard Cite

“…Laws need to be enhanced to reduce access and use by children. Previous research indicates that laws regulating the synthesis, retail and use of delta‐9 THC help to reduce access to those aged under 21, as products are sold only in licensed and regulated dispensaries that use consistent age verification procedures [124–126]. The CDC and FDA recommend implementing age restrictions, requiring child‐safe packaging, reducing youth‐oriented marketing, consistent contaminant and safety testing, product labeling requirements, reporting the total THC content on cannabis products and mentioning the potential for psychoactivity [4, 33].…”

Section: Discussionmentioning

confidence: 99%

Delta‐8 tetrahydrocannabinol: a scoping review and commentary

et al. 2023

View full text Add to dashboard Cite

Background and Aims Delta‐8 tetrahydrocannabinol (THC) is a psychoactive substance from the Cannabis plant that has been rising in popularity in the United States since the 2018 US Farm Bill implicitly legalized it. This study reviewed research from peer‐reviewed and non‐peer‐reviewed (e.g. anecdotal and news) reports related to delta‐8 THC to summarize current knowledge and implications for public health and safety. Methods A scoping review was conducted using PubMed, Scopus, Google Scholar and Google as search engines, leading to the identification of 103 documents that were summarized. The themes that emerged were (1) legality, (2) use (popularity, motives, psychoactivity/potency, benefits/consequences), (3) synthesis (byproducts, laboratory testing) and (4) retail (availability, price, packaging, youth‐oriented marketing). A second author independently coded 20% of the documents, which verified the categorization of articles by these emergent themes. Results Most research used animal/cell models or focused upon ways to identify the chemical structure of delta‐8 THC in various products. Findings suggest that people often use delta‐8 THC as a substitute for other substances. Anecdotally, delta‐8 THC is a less potent psychoactive than delta‐9 THC; however, several negative consequences have been reported. There is no federal age restriction for purchase/possession of delta‐8 THC products. Delta‐8 THC is readily accessible on‐line, is typically less expensive than delta‐9 THC and is often marketed in ways that would seemingly appeal to children. There are no regulations on synthesis, resulting in products being contaminated and/or yielding inconsistent effects. There have been thousands of calls to US poison control centers due to accidental delta‐8 THC exposure among minors. Conclusions Most research on delta‐8 THC is largely anecdotal, not peer‐reviewed and does not involve human subjects. Future research should examine delta‐8 THC use using nationally representative samples to more clearly understand the prevalence and consequences of use. Laws are needed to mitigate the risks of using delta‐8 THC, particularly quality control of synthesis and minimum purchase age.

show abstract